Literature DB >> 25106025

Experimental validation of the hyperpolarized 129 Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease.

Neil J Stewart1, General Leung1, Graham Norquay1, Helen Marshall1, Juan Parra-Robles1, Philip S Murphy2, Rolf F Schulte3, Charlie Elliot4,5, Robin Condliffe4,5, Paul D Griffiths1, David G Kiely4,5, Moira K Whyte4, Jan Wolber1,6, Jim M Wild1.   

Abstract

PURPOSE: To assess the sensitivity of the hyperpolarized 129 Xe chemical shift saturation recovery (CSSR) technique for noninvasive quantification of changes to lung microstructure and function in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc).
METHODS: Ten healthy volunteers, four subjects with SSc and four with IPF were scanned at 1.5 T. A CSSR pulse sequence was implemented using binomial-composite radiofrequency pulses to monitor 129 Xe magnetization in tissues and blood plasma (T/P) and red blood cells (RBCs). The dynamics of 129 Xe uptake into these compartments were fitted with three existing analytical models of gas diffusion to extract parameters of lung physiology. These parameters were quantitatively compared between models.
RESULTS: Uptake of xenon into the pulmonary capillaries was impaired in subjects with IPF and SSc. Statistically significant septal thickening was measured by 129 Xe CSSR in IPF patients. Preliminary data suggests age-dependent alterations to septal thickness in healthy volunteers. These findings were reproduced using each of the literature models. CSSR-derived parameters were compared with gold-standard indicators of pulmonary function; diffusing capacity of carbon monoxide and pulmonary transit-time.
CONCLUSIONS: CSSR with hyperpolarized 129 Xe is sensitive to pathology-induced degradation of lung structure/function and shows promise for quantification of disease severity and monitoring treatment response. Magn Reson Med 74:196-207, 2015.
© 2014 Wiley Periodicals, Inc. © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  gas-exchange; hyperpolarized gas; idiopathic pulmonary fibrosis; lung physiology; systemic sclerosis; xenon-129

Year:  2014        PMID: 25106025     DOI: 10.1002/mrm.25400

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  27 in total

1.  Repeatability of regional pulmonary functional metrics of Hyperpolarized 129 Xe dissolved-phase MRI.

Authors:  Andrew D Hahn; Jeff Kammerman; Michael Evans; Wei Zha; Robert V Cadman; Keith Meyer; Nathan Sandbo; Sean B Fain
Journal:  J Magn Reson Imaging       Date:  2019-04-10       Impact factor: 4.813

2.  Uncovering a third dissolved-phase 129 Xe resonance in the human lung: Quantifying spectroscopic features in healthy subjects and patients with idiopathic pulmonary fibrosis.

Authors:  Scott H Robertson; Rohan S Virgincar; Elianna A Bier; Mu He; Geoffrey M Schrank; Rose Marie Smigla; Craig Rackley; H Page McAdams; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2016-11-08       Impact factor: 4.668

Review 3.  Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Sydney B Montesi; Peter Caravan
Journal:  Curr Rheumatol Rep       Date:  2019-04-25       Impact factor: 4.592

Review 4.  Hyperpolarized gas MRI in pulmonology.

Authors:  Agilo Luitger Kern; Jens Vogel-Claussen
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

Review 5.  The role of hyperpolarized 129xenon in MR imaging of pulmonary function.

Authors:  Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain
Journal:  Eur J Radiol       Date:  2016-09-16       Impact factor: 3.528

6.  Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolved 129Xe MRI.

Authors:  Peter J Niedbalski; Elianna A Bier; Ziyi Wang; Matthew M Willmering; Bastiaan Driehuys; Zackary I Cleveland
Journal:  J Appl Physiol (1985)       Date:  2020-06-18

7.  Investigating biases in the measurement of apparent alveolar septal wall thickness with hyperpolarized 129Xe MRI.

Authors:  Kai Ruppert; Faraz Amzajerdian; Yi Xin; Hooman Hamedani; Luis Loza; Tahmina Achekzai; Ian F Duncan; Harrilla Profka; Yiwen Qian; Mehrdad Pourfathi; Stephen Kadlecek; Rahim R Rizi
Journal:  Magn Reson Med       Date:  2020-06-18       Impact factor: 4.668

8.  Using Hyperpolarized Xenon-129 MRI to Quantify Early-Stage Lung Disease in Smokers.

Authors:  Kai Ruppert; Kun Qing; James T Patrie; Talissa A Altes; John P Mugler
Journal:  Acad Radiol       Date:  2018-12-03       Impact factor: 3.173

9.  Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis.

Authors:  Jennifer M Wang; Scott H Robertson; Ziyi Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Rose Marie Smigla; Thomas G O'Riordan; John Sundy; Lukas Ebner; Craig R Rackley; Page McAdams; Bastiaan Driehuys
Journal:  Thorax       Date:  2017-08-31       Impact factor: 9.139

10.  A protocol for quantifying cardiogenic oscillations in dynamic 129 Xe gas exchange spectroscopy: The effects of idiopathic pulmonary fibrosis.

Authors:  Elianna A Bier; Scott H Robertson; Geoffry M Schrank; Craig Rackley; Joseph G Mammarappallil; Sudarshan Rajagopal; H Page McAdams; Bastiaan Driehuys
Journal:  NMR Biomed       Date:  2018-11-20       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.